Merck pares 2010 forecast, despite beat in quarter

Published August 3, 2010

Merck pares 2010 forecast, despite beat in quarter
Merck and Co issued a more cautious 2010 profit outlook on Friday and reported disappointing second-quarter sales of its vaccines and Singulair asthma drug, sending its shares down 2 percent.
Read more on Reuters via Yahoo! News

Another Pill That Could Change Women’s Lives
Little white pills costing less than each could revolutionize abortion worldwide.
Read more on New York Times

DynaMed™ Drug Topics Now Include Medication Cost Assistance Program Information from NeedyMeds
~Links Within DynaMed™ Drug Topics Help Clinicians Provide Pharmaceutical Cost Assistance to Patients ~
Read more on PRWeb via Yahoo! News